GC1008

fresolimumab

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GC1008, covering 2014-03-19 to 2024-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Imaging Study of GC1008 in Glioma [Phase 2]